This link has been bookmarked by 35 people . It was first bookmarked on 03 Jan 2009, by Brent Cochran.
-
16 May 10
Framboise Surmenodoctors,pharmaceutical industry,medical practice
-
08 Dec 09
-
04 Nov 09
-
18 Oct 09
-
-
Its extensive ties to physicians, particularly senior faculty at prestigious medical schools, affect the results of research, the way medicine is practiced, and even the definition of what constitutes a disease.
-
A review of seventy-four clinical trials of antidepressants, for example, found that thirty-seven of thirty-eight positive studies were published.[8] But of the thirty-six negative studies, thirty-three were either not published or published in a form that conveyed a positive outcome.
-
It seems that the strategy of the drug marketers—and it has been remarkably successful—is to convince Americans that there are only two kinds of people: those with medical conditions that require drug treatment and those who don't know it yet
-
Given its importance, you might think that the DSM represents the authoritative distillation of a large body of scientific evidence. But Lane, using unpublished records from the archives of the American Psychiatric Association and interviews with the princi-pals, shows that it is instead the product of a complex of academic politics, personal ambition, ideology, and, perhaps most important, the influence of the pharmaceutical industry.
-
-
24 May 09
-
25 Apr 09
-
20 Apr 09
-
27 Mar 09
-
07 Mar 09
-
14 Feb 09
Neal AggarwalBook Review: Side Effects: A Prosecutor, a Whistleblower, and a Best selling Antidepressant on Trial. An eye-opening book I recently read that echoes a lot of my sentiments. This is a link to a review that starts like this:
Recently Senator Charles Grass -
28 Jan 09
-
16 Jan 09
-
13 Jan 09
-
Drug Companies & Doctors: A Story of Corruption
-
-
08 Jan 09
-
04 Jan 09
-
03 Jan 09
Disease-mongering =the marketing strategy by pharmaceuticals to promote diseases to fit drugs instead of promoting drugs to treat diseases.
nybooks marcia_angell reviews:books pharmaceutical_industry conflicts_of_interest FDA thought-leaders alison_bass GlaxoSmithKline experimental_design clinical_trials research_designs disease-mongering melody_petersen christopher_lane linkingthinking evalu
-
02 Jan 09
-
01 Jan 09
-
No one knows the total amount provided by drug companies to physicians, but I estimate from the annual reports of the top nine US drug companies that it comes to tens of billions of dollars a year. By such means, the pharmaceutical industry has gained enormous control over how doctors evaluate and use its own products. Its extensive ties to physicians, particularly senior faculty at prestigious medical schools, affect the results of research, the way medicine is practiced, and even the definition of what constitutes a disease.
-
No one knows the total amount provided by drug companies to physicians, but I estimate from the annual reports of the top nine US drug companies that it comes to tens of billions of dollars a year. By such means, the pharmaceutical industry has gained enormous control over how doctors evaluate and use its own products. Its extensive ties to physicians, particularly senior faculty at prestigious medical schools, affect the results of research, the way medicine is practiced, and even the definition of what constitutes a disease.
-
-
30 Dec 08
-
-
29 Dec 08
-
27 Dec 08
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.